Shenzhen Zhumeng Times Technology

Shenzhen Zhumeng Times Technology is a life sciences tool company that specializes in high-throughput microfluidic technology and single-cell analysis systems. Established in 2020 and headquartered in Shenzhen, the company develops automated platforms such as the Dreamer series to simplify single-cell sequencing library preparation. Their proprietary microfluidic chips and instruments are designed to improve the efficiency and scalability of genomic research in fields like oncology and immunology. By providing accessible and high-performance tools, Zhumeng Times aims to accelerate the understanding of cellular diversity and its role in disease. The company has received significant backing from prominent venture capital firms, including Sequoia China and Matrix Partners.